All variables that in these analyses remained associated with TF at a significance level of 90% (p≤ 0.1) (geographical area of exposure/infection, clinical form, lesion age ≥ 6 months, complete or incomplete therapeutic scheme, presence of treatment interruptions) were included in the MV analysis using LBR. The gene discussed is TF; the disease is infection.